¡®Era of once-weekly growth hormones¡¦adherence is key¡¯
By Hwang, Byung-woo | translator Alice Kang
24.09.13 05:32:03
°¡³ª´Ù¶ó
0
Growth hormone deficiency drug Ngenla enters the market¡¦ convenience in administration is an advantage
Pain management remains a challenge compared to once-daily options... improvement in quality of life is key
"The frequency of drug administration is an important factor in the treatment of growth hormone deficiency. The emergence of a once-weekly dosing option is significant in terms of treatment adherence.¡¯
With the market for growth hormone injections rising rapidly, the diversified treatment options have been increasing market interest.
The introduction of once-weekly treatment options to the once-daily regimen has emphasized the importance of choosing the right treatment option for patients.
Professor Masanobu Kawai (Osaka Women's and Children's Hospital( focused on the effect of the once-weekly growth hormone deficiency treatment.
¡ãProfessor Masanobu Kawai, Osaka Women
Growth hormon
Hwang, Byung-woo(tuai@dailypharm.com)
If you want to see the full article, please JOIN US (click)